INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL

INTERFERON-ALPHA(IFN-ALPHA) PROLONGS SURVIVAL FOR PATIENTS WITH CML IN CHRONIC PHASE - PRELIMINARY-RESULTS OF THE UK MRC RANDOMIZED MULTICENTER TRIAL

Bibliografske podrobnosti
Main Authors:	Allan, N, Shepherd, P, Richards, S
Format:	Journal article
Izdano:	1994

Podobne knjige/članki

Progress with interferon in CML--results of the MRC UK CML III study.
od: Shepherd, P, et al.
Izdano: (1996)

A randomised comparison of low or high dose IFN-alpha in newly diagnosed CML patients shows no difference in major cytogenetic response rate or survival between the two groups - Results of MRC CML V and HOVON 20 trials.
od: Shepherd, P, et al.
Izdano: (2001)

Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration.
od: Shepherd, P, et al.
Izdano: (1995)

The Combination of Interferon-Alpha and Ponatinib Enables Faster and Deeper Molecular Responses in Patient with De Novo Blast Crisis of CML: Interferon-Alpha May Return as a CML Treatment
od: Kunio Hayashi, et al.
Izdano: (2021-01-01)

The long term outcome of the patients with chronic myeloid leukemia (CML) who have achieved complete cytogenetic response (CCgR) to interferon-alpha (IFN alpha). A collaborative European study of 317 cases.
od: Bonifazi, F, et al.
Izdano: (2001)

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.
od: Allan, N, et al.
Izdano: (1995)

Interferon alpha (IFN-α) in systemic lupus erythematosus (SLE)
od: Sara Moqbil, et al.
Izdano: (2022-11-01)

Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia.
od: Shepherd, P, et al.
Izdano: (1994)

Interferon-alpha therapy in chronic myeloid leukaemia is probably better than hydroxyurea alone.
od: Allan, N, et al.
Izdano: (1995)

Interferon-alpha: results from randomized trials.
od: Richards, S
Izdano: (1997)

Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
od: Shepherd, P, et al.
Izdano: (1991)

A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
od: Le Bon, A, et al.
Izdano: (2006)

TREATMENT OF ACUTE HEPATITIS-C WITH ALPHA-INTERFERON IN HYPOGAMMAGLOBULINEMIA - THE UK GAMMAGARD OUTBREAK
od: Healey, C, et al.
Izdano: (1995)

Schwannoma response to interferon alpha
od: Jennifer Novak, et al.
Izdano: (2017-12-01)

First line treatment of acute and chronic ATLL with zidovudine (AZT) and interferon alpha (IFN-α): haematological and molecular responses
od: Fields Paul, et al.
Izdano: (2011-06-01)

Production of alpha-interferon in Lactococcus lactis
od: Bayat, Omid
Izdano: (2013)

Interferon Alpha Association with Neuromyelitis Optica
od: Nasrin Asgari, et al.
Izdano: (2013-01-01)

Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)
od: Caterina Lapenta, et al.
Izdano: (2024-09-01)

The immunoregulation effect of alpha 1-antitrypsin prolong β-cell survival after transplantation.
od: Yun Wang, et al.
Izdano: (2014-01-01)

Interferon alpha in the pathogenesis and treatment Japanese encephalitis
od: Solomon, T, et al.
Izdano: (2004)

Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon
od: Patrícia Alessandra Dastoli, et al.
Izdano: (2011-02-01)

The MRC/BHF Heart Protection Study: preliminary results.
od: Collins, R, et al.
Izdano: (2002)

Intracellular production of IFN-alpha 2b in Lactococcus lactis
od: Bayat, Omid, et al.
Izdano: (2014)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
od: Megen C. Wittling, et al.
Izdano: (2021-01-01)

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
od: Romero, A, et al.
Izdano: (2006)

Retraction: The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong β-Cell Survival after Transplantation.
od: PLOS ONE Editors
Izdano: (2018-01-01)

Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol
od: Yan-Ming Zeng, et al.
Izdano: (2020-05-01)

Pathways of IFN-alpha Activation in Patients with Cervical Intraepithelial Neoplasia (CIN)
od: Nelson Ranieri Tirone, et al.
Izdano: (2021-11-01)

Neuromyelitis optica in patients with increased interferon alpha concentrations
od: Williams, J, et al.
Izdano: (2019)

Interferon-alpha treatment for chronic hepatitis C in children
od: A Yüce, et al.
Izdano: (2000-01-01)

The effect of interferon alpha administration on cytokine levels in sheep
od: Devran Coşkun, et al.
Izdano: (2020-12-01)

Pharmacokinetic studies of the recombinant bovine interferon-alpha in cattle
od: Hai-Yang YU, et al.
Izdano: (2018-10-01)

Anti-interferon alpha autoantibodies and their significance in COVID-19
od: S. S. Petrikov, et al.
Izdano: (2022-05-01)

Different Biological Activities of Specific Interferon Alpha Subtypes
od: Kim J. Hasenkrug, et al.
Izdano: (2019-08-01)

Tolerance and Efficacy of Interferon-alpha in Hemodialysis Patients in Tripoli
od: Buargub Mahdia, et al.
Izdano: (2006-01-01)

High dose interferon-alpha induction therapy is associated with a profound loss of IL-2 and IFN-gamma secreting HCV specific T-cells
od: Gelderblom, H, et al.
Izdano: (2007)

Somatic pain associated with initiation of interferon-alpha (IFN-α) plus ribavirin (RBV) therapy in chronic HCV patients: A prospective study
od: Chih Ying Lin, et al.
Izdano: (2020-02-01)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
od: Kinsey, S, et al.
Izdano: (2002)

TSG-6 Downregulates IFN-Alpha and TNF-Alpha Expression by Suppressing IRF7 Phosphorylation in Human Plasmacytoid Dendritic Cells
od: L. Kui, et al.
Izdano: (2017-01-01)

Significance of the interferon (IFN) in the therapy
od: Sabina Mahmutović, et al.
Izdano: (2004-11-01)